Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

39.44
+0.47001.21%
Volume:5.31M
Turnover:211.46M
Market Cap:79.85B
PE:25.32
High:40.38
Open:40.19
Low:39.23
Close:38.97
Loading ...

GSK Q1 Core Earnings, Revenue Increase

MT Newswires Live
·
Yesterday

Britiain's GSK Says "Well Positioned" to Absorb Possible Pharma Tariff Hit

Reuters
·
Yesterday

GSK Rises Wednesday, Outperforms Market

Dow Jones
·
1 hour ago

European Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday Trading

MT Newswires Live
·
Yesterday

Tariff turmoil prompts cloudy forecasts from companies for the year ahead

Associated Press Finance
·
Yesterday

Earnings Movers | Snap Plunges 17%; Norwegian Cruise Tumbles 11%; Tenable and First Solar Sink 10%; Starbucks Drops 7%

Tiger Newspress
·
Yesterday

GlaxoSmithKline (GSK) Gets a Hold from UBS

TIPRANKS
·
Yesterday

Britain's GSK Asserts It Is 'Well Positioned' To Mitigate Potential Tariffs After Strong Q1 Cancer And HIV Drug Sales

Benzinga
·
Yesterday

Pre-Bell|U.S. Futures Drop After ADP and GDP Datas; Super Micro Plunges 19%; Snap Tumbles 15%; Starbucks Sinks 10%

Tiger Newspress
·
Yesterday

Jefferies Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Yesterday

GSK (GSK) Q1 Earnings Surpass Estimates

Zacks
·
Yesterday

GSK Investors Turn to U.S. Policy Outlook After Solid Results -- Market Talk

Dow Jones
·
Yesterday

GSK Affirms Its FY25 Guidance And Expects Its Turnover To Increase Between 3%-5% And Core Operating Profit To Increase Between 6%-8%. Core EPS Is Expected To Increase Between 6%-8%

Benzinga
·
Yesterday

J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Yesterday

GSK Q1 Adj. EPS $1.13 Beats $1.04 Estimate, Sales $9.46B Beat $7.46B Estimate

Benzinga
·
Yesterday

GSK's Specialty Meds Sustain Growth, Blenrep Comeback Remains Key -- Market Talk

Dow Jones
·
Yesterday

GSK plc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

GSK Outperforms Expectations Despite RSV Vaccine Setback -- Market Talk

Dow Jones
·
Yesterday

GSK Reports Strong Q1 2025 Performance with Specialty Medicines Leading Growth

TIPRANKS
·
Yesterday

GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs -- Update

Dow Jones
·
Yesterday